ALPHA TEKNOVA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ALPHA TEKNOVA, INC. (TKNO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.21 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-03-30
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-09-30 was 3.31M shares, a 28.48% increase year-over-year.
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-06-30 was 3.82M shares, a 67.04% decline year-over-year.
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 2.84M shares, a 75.46% decline year-over-year.
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-09-30 was 2.58M shares, a 72.41% decline year-over-year.
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.21M shares, a 52.91% decline from fiscal 2021.
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 6.81M shares, a 27.06% decline from fiscal 2020.
- ALPHA TEKNOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 9.34M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2022-12-31 | 3.21M shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 3.31M shares 10-Q · filed 2022-11-14 | 3.13M shares 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 3.82M shares 10-Q · filed 2022-08-11 | 3.62M shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 2.84M shares 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 6.81M shares 10-K · filed 2023-03-30 | |||
| 2021-09-30 | 2.58M shares 10-Q · filed 2022-11-14 | 8.59M shares 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 11.58M shares 10-Q · filed 2022-08-11 | 11.59M shares 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | 11.59M shares 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 9.34M shares 10-K · filed 2022-03-18 | |||
| 2020-09-30 | 9.34M shares 10-Q · filed 2021-11-12 | 9.34M shares 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 9.34M shares 10-Q · filed 2021-08-13 | 9.34M shares 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |